Driehaus Capital Management’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-135,381
Closed -$38.6M – 460
2023
Q2
$38.6M Buy
+135,381
New +$37.6M 0.49% 53
2023
Q1
– Sell
-45,726
Closed -$9.4M – 449
2022
Q4
$9.4M Sell
45,726
-148,802
-76% -$37.6M 0.14% 211
2022
Q3
$54.1M Sell
194,528
-37,463
-16% -$9.5M 0.82% 22
2022
Q2
$44.4M Buy
231,991
+10,985
+5% +$1.94M 0.72% 30
2022
Q1
$45.8M Buy
221,006
+5,126
+2% +$845K 0.56% 39
2021
Q4
$38.5M Buy
215,880
+37,638
+21% +$7.42M 0.39% 80
2021
Q3
$36.7M Buy
178,242
+80,925
+83% +$15.9M 0.44% 67
2021
Q2
$18.5M Buy
+97,317
New +$15.9M 0.24% 140

Other funds holding SWAV

Driehaus Capital Management's SWAV Position: Q3 2023 in Review

Driehaus Capital Management sold out of Shockwave Medical (SWAV) in Q3 2023, closing a stake of 135,381 shares — an estimated $38.6M sold.

Driehaus Capital Management first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $54.1M in Q3 2022. 411 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Driehaus Capital Management reported no remaining Shockwave Medical position as of Q3 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 135,381 Shockwave Medical shares in Q3 2023, an estimated $38.6M.
  • Driehaus Capital Management first reported a position in Shockwave Medical in Q2 2021 and held it in 8 quarters.
  • Driehaus Capital Management's Shockwave Medical position peaked at $54.1M in Q3 2022.
  • 411 funds tracked by Wall St. Rank held Shockwave Medical as of Q3 2023.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.